# Inflammatory Caspases Drive Pyroptosis in Acute Lung Injury

**Authors:** Bohao Liu, Ruyuan He, Lin Zhang, Bo Hao, Wenyang Jiang, Wei Wang, Qing Geng

PMC · DOI: 10.3389/fphar.2021.631256 · 2021-02-05

## TL;DR

This paper explores how inflammatory caspases trigger pyroptosis, a type of cell death, in acute lung injury and how this process contributes to inflammation and disease progression.

## Contribution

The paper reviews the role of pyroptosis and inflammatory caspases in acute lung injury and suggests new research directions.

## Key findings

- Pyroptosis is driven by inflammatory caspases and contributes to inflammation in acute lung injury.
- Inhibition of inflammasomes, which initiate pyroptosis, is a potential treatment strategy for acute lung injury.
- Pyroptosis activation varies across different lung cell types and influences downstream pathways.

## Abstract

Acute lung injury (ALI), a critical respiratory disorder that causes diffuse alveolar injury leads to high mortality rates with no effective treatment. ALI is characterized by varying degrees of ventilation/perfusion mismatch, severe hypoxemia, and poor pulmonary compliance. The diffuse injury to cells is one of most important pathological characteristics of ALI. Pyroptosis is a form of programmed cell death distinguished from apoptosis induced by inflammatory caspases, which can release inflammatory cytokines to clear cells infected by pathogens and promote monocytes to reassemble at the site of injury. And pyroptosis not only promotes inflammation in certain cell types, but also regulates many downstream pathways to perform different functions. There is increasing evidence that pyroptosis and its related inflammatory caspases play an important role in the development of acute lung injury. The main modes of activation of pyroptosis is not consistent among different types of cells in lung tissue. Meanwhile, inhibition of inflammasome, the key to initiating pyroptosis is currently the main way to treat acute lung injury. The review summarizes the relationship among inflammatory caspases, pyroptosis and acute lung injury and provides general directions and strategies to conduct further research.

## Linked entities

- **Diseases:** acute lung injury (MONDO:0006502), ALI (MONDO:0006502)

## Full-text entities

- **Genes:** Il9 (interleukin 9) [NCBI Gene 16198] {aka Il-9, P40}, CASP4 (caspase 4) [NCBI Gene 837] {aka CASP-4, ICE(rel)II, ICEREL-II, ICH-2, Mih1, Mih1/TX}, CASP5 (caspase 5) [NCBI Gene 838] {aka ICE(rel)III, ICEREL-III, ICH-3}, Nlrp1b (NLR family, pyrin domain containing 1B) [NCBI Gene 637515] {aka Nalp1b}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Casp8 (caspase 8) [NCBI Gene 12370] {aka CASP-8, FLICE, MACH, Mch5}, Nlrp4e (NLR family, pyrin domain containing 4E) [NCBI Gene 446099] {aka 4930406H16Rik, Nalp-epsilon, Nalp4e, Nlrp4}, MPO (myeloperoxidase) [NCBI Gene 4353], HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}, Il18 (interleukin 18) [NCBI Gene 16173] {aka Igif, Il-18}, Tlr2 (toll-like receptor 2) [NCBI Gene 24088] {aka Ly105}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, Myd88 (myeloid differentiation primary response gene 88) [NCBI Gene 17874], Gsdmd (gasdermin D) [NCBI Gene 69146] {aka 1810036L03Rik, DF5L, Dfna5l, GsdmD-1, Gsdmdc1, M2-4}, Eif2ak2 (eukaryotic translation initiation factor 2-alpha kinase 2) [NCBI Gene 19106] {aka 2310047A08Rik, 4732414G15Rik, Pkr, Prkr, Tik}, Pycard (PYD and CARD domain containing) [NCBI Gene 66824] {aka 9130417A21Rik, Asc, CARD5, TMS-1, TNS1, masc}, Tlr3 (toll-like receptor 3) [NCBI Gene 142980], TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, Dclk3 (doublecortin-like kinase 3) [NCBI Gene 245038] {aka C730036H08, Dcamkl3}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Cxcr4 (C-X-C motif chemokine receptor 4) [NCBI Gene 12767] {aka CD184, CXC-R4, CXCR-4, Cmkar4, LESTR, PB-CKR}, Panx1 (pannexin 1) [NCBI Gene 55991], AGER (advanced glycosylation end-product specific receptor) [NCBI Gene 177] {aka RAGE, SCARJ1, sRAGE}, Hmgb1 (high mobility group box 1) [NCBI Gene 15289] {aka HMG-1, Hmg1, SBP-1, p30}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, Irf1 (interferon regulatory factor 1) [NCBI Gene 16362] {aka Irf-1}, Aim2 (absent in melanoma 2) [NCBI Gene 383619] {aka Gm1313, Ifi210}, Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 20848] {aka 1110034C02Rik, Aprf}, Casp1 (caspase 1) [NCBI Gene 12362] {aka ICE, Il1bc}, Cgas (cyclic GMP-AMP synthase) [NCBI Gene 214763] {aka E330016A19Rik, Mb21d1}, Gfer (growth factor, augmenter of liver regeneration) [NCBI Gene 11692] {aka Alr, ERV1}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Socs1 (suppressor of cytokine signaling 1) [NCBI Gene 12703] {aka Cish1, Cish7, JAB, SOCS-1, SSI-1}, Mapk14 (mitogen-activated protein kinase 14) [NCBI Gene 26416] {aka CSBP2, Crk1, Csbp1, Mxi2, PRKM14, PRKM15}, Ly96 (lymphocyte antigen 96) [NCBI Gene 17087] {aka ESOP-1, MD-2, MD2}, Gsdme (gasdermin E) [NCBI Gene 54722] {aka 2310037D07Rik, 4932441K13Rik, Dfna5, Dfna5h, EG14210, Fin15}, Nlrp1a (NLR family, pyrin domain containing 1A) [NCBI Gene 195046] {aka CARD7, DEFCAP, Gm14, Gm15, NAC, Nalp1}, CASP9 (caspase 9) [NCBI Gene 842] {aka APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56}, Yap1 (yes-associated protein 1) [NCBI Gene 22601] {aka Yap, Yap65, Yki, Yorkie}, Dcpp1 (demilune cell and parotid protein 1) [NCBI Gene 13184] {aka Dcpp, Dcpp-1, p20}, Rhd (Rh blood group, D antigen) [NCBI Gene 19746] {aka Rh, Rhced, Rhl1}, Il33 (interleukin 33) [NCBI Gene 77125] {aka 9230117N10Rik, Il-33, Il1f11, NF-HEV}, Dhx58 (DExH-box helicase 58) [NCBI Gene 80861] {aka B430001I08Rik, D11Lgp2e, LPG2, Lgp2, RLR-3}, Sting1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 72512] {aka 2610307O08Rik, ERIS, MPYS, Mita, STING, STING-beta}, Cxcl12 (C-X-C motif chemokine ligand 12) [NCBI Gene 20315] {aka Pbsf, Scyb12, Sdf1, Tlsf, Tpar1}, S100a10 (S100 calcium binding protein A10 (calpactin)) [NCBI Gene 20194] {aka 42C, CAL12, CLP11, Cal1l, p10, p11}, Il1rl1 (interleukin 1 receptor-like 1) [NCBI Gene 17082] {aka DER4, Fit-1, Ly84, ST2L, St2, St2-rs1}, Mefv (Mediterranean fever) [NCBI Gene 54483] {aka FMF, TRIM20, pyrin}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}
- **Diseases:** bacterial infections (MESH:D001424), ARDS (MESH:D012128), molecular patterns (MESH:C567116), cardiovascular disease (MESH:D002318), alveolar injury (MESH:D014947), ALI (MESH:D055371), HS (MESH:D012771), inflammatory response (MESH:D018746), lung infection (MESH:D012141), AMs (MESH:D055501), kidney injury (MESH:D007674), lung inflammation (MESH:D011014), necrosis (MESH:D009336), COVID-19 (MESH:D000086382), endothelial cell proliferation disorders (MESH:D000090362), MTDs (MESH:D028361), brain injury (MESH:D001930), Ventilator (MESH:D053717), PRRs (MESH:D020238), HALI (MESH:D055370), hypoxemia (MESH:D000860), respiratory disorder (MESH:D012131), gram-negative bacterial infection (MESH:D016905), infection (MESH:D007239), IR (MESH:D015427), Hyperoxia (MESH:D018496), inflammatory caspases (MESH:D056735), shock (MESH:D012769), Pulmonary edema (MESH:D011654), liver injury (MESH:D017093), EC (MESH:D055954), endothelial dysfunction (MESH:D014652), lung damage (MESH:D008171), VILI (MESH:D055397), Inflammatory (MESH:D007249), GSDMD-N (MESH:D014808)
- **Chemicals:** K+ (MESH:D011188), dopamine (MESH:D004298), SB203580 (MESH:C093642), Ac-YVAD-CMK (MESH:C098738), ATP (MESH:D000255), water (MESH:D014867), Hcy (MESH:D006710), apocynin (MESH:C056165), phosphatidylinositol (MESH:D010716), Ca2+ (-), andrographolide (MESH:C030419), DHM (MESH:C472036), salidroside (MESH:C009172), LPS (MESH:D008070), ROS (MESH:D017382), lipid A (MESH:D008050), melatonin (MESH:D008550), oridonin (MESH:C011959)
- **Species:** Pseudomonas aeruginosa PAO1 (strain) [taxon 208964], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC7892432/full.md

---
Source: https://tomesphere.com/paper/PMC7892432